Literature DB >> 10907941

Grading of chemotherapy-induced peripheral neuropathy.

T J Postma1, J J Heimans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10907941     DOI： 10.1023/a:1008345613594

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  43 in total

1.  Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study.

Authors:  Bingjie Ding; Zhixiang Wang; Xuejie Jiang; Xiaodong Li; Chunli Wang; Qingxiu Zhong; Ling Jiang; Min Dai; Y U Zhang; Q I Wei; Fanyi Meng
Journal:  Mol Clin Oncol       Date:  2015-07-21

2.  Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials.

Authors:  Shun Kishimoto; Nobu Oshima; Matthew Rinker; Murali C Krishna; Naoko Takebe
Journal:  Eur J Cancer       Date:  2019-05-24       Impact factor: 9.162

3.  Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?

Authors:  Mauricio Burotto; Antonio Tito Fojo
Journal:  Oncologist       Date:  2013

4.  Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?

Authors:  Andreas A Argyriou; Panagiotis Polychronopoulos; Angelos Koutras; Gregoris Iconomou; Alexander Iconomou; Haralabos P Kalofonos; Elisabeth Chroni
Journal:  Support Care Cancer       Date:  2005-02-15       Impact factor: 3.603

5.  Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.

Authors:  Molly McFatrich; Jennifer Brondon; Nicole R Lucas; Pamela S Hinds; Scott H Maurer; Jennifer W Mack; David R Freyer; Shana S Jacobs; Justin N Baker; Catriona Mowbray; Mian Wang; Sharon M Castellino; Allison Barz Leahy; Bryce B Reeve
Journal:  Cancer       Date:  2019-09-25       Impact factor: 6.860

Review 6.  Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.

Authors:  Gerardo Gutiérrez-Gutiérrez; María Sereno; Ambrosio Miralles; Enrique Casado-Sáenz; Eduardo Gutiérrez-Rivas
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

7.  Impact of oxaliplatin-induced neuropathy: a patient perspective.

Authors:  Barbara K Bennett; Susanna B Park; Cindy S-Y Lin; Michael L Friedlander; Matthew C Kiernan; David Goldstein
Journal:  Support Care Cancer       Date:  2012-03-17       Impact factor: 3.603

Review 8.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

Review 9.  Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.

Authors:  Allyson J Ocean; Linda T Vahdat
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

10.  A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.

Authors:  R Michael Baldwin; Kouros Owzar; Hitoshi Zembutsu; Aparna Chhibber; Michiaki Kubo; Chen Jiang; Dorothy Watson; Rachel J Eclov; Joel Mefford; Howard L McLeod; Paula N Friedman; Clifford A Hudis; Eric P Winer; Eric M Jorgenson; John S Witte; Lawrence N Shulman; Yusuke Nakamura; Mark J Ratain; Deanna L Kroetz
Journal:  Clin Cancer Res       Date:  2012-07-27       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.